Suppr
超能文献

Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor.

作者信息

Stewart David J, Erasmus Jeremy J

出版信息

J Thorac Oncol. 2011 Jul;6(7):1149-51. doi: 10.1097/JTO.0b013e318223931f.

DOI:10.1097/JTO.0b013e318223931f

PMID:21847039

Abstract

摘要

相似文献

Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor.

J Thorac Oncol. 2011 Jul;6(7):1149-51. doi: 10.1097/JTO.0b013e318223931f.

Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor.

J Thorac Oncol. 2011 Jul;6(7):1287-9. doi: 10.1097/JTO.0b013e318219ab87.

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

J Thorac Oncol. 2011 Jul;6(7):1152-61. doi: 10.1097/JTO.0b013e318216ee52.

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.

Lung Cancer. 2006 Jun;52(3):373. doi: 10.1016/j.lungcan.2006.03.001. Epub 2006 Apr 18.

Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.

Jpn J Clin Oncol. 2012 Jun;42(6):528-33. doi: 10.1093/jjco/hys042. Epub 2012 Mar 28.

Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.

Respir Investig. 2014 Mar;52(2):82-91. doi: 10.1016/j.resinv.2013.07.007. Epub 2013 Aug 30.

Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.

PLoS One. 2015 May 20;10(5):e0128360. doi: 10.1371/journal.pone.0128360. eCollection 2015.

First case of A859T epidermal growth factor receptor mutation responding to erlotinib.

J Thorac Oncol. 2011 Mar;6(3):639-40. doi: 10.1097/JTO.0b013e3182037c0c.

Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.

J Thorac Oncol. 2014 Apr;9(4):506-11. doi: 10.1097/JTO.0000000000000095.

Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Med Oncol. 2016 Nov;33(11):129. doi: 10.1007/s12032-016-0843-8. Epub 2016 Oct 18.

引用本文的文献

A Need for More Molecular Profiling in Brain Metastases.

Front Oncol. 2022 Jan 25;11:785064. doi: 10.3389/fonc.2021.785064. eCollection 2021.

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles.

Neurooncol Adv. 2021 Nov 27;3(Suppl 5):v35-v42. doi: 10.1093/noajnl/vdab105. eCollection 2021 Nov.

The relationship between cerebrospinal fluid metastasis and gene mutations in non-small-cell lung cancer patients.

Int J Clin Exp Pathol. 2020 Jul 1;13(7):1662-1668. eCollection 2020.

Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: A case report.

Medicine (Baltimore). 2019 Jan;98(4):e14182. doi: 10.1097/MD.0000000000014182.

Targeted drugs for systemic therapy of lung cancer with brain metastases.

Oncotarget. 2017 Dec 22;9(4):5459-5472. doi: 10.18632/oncotarget.23616. eCollection 2018 Jan 12.

Why are we failing to implement imaging studies with radiolabelled new molecular entities in early oncology drug development?

ScientificWorldJournal. 2014;2014:269605. doi: 10.1155/2014/269605. Epub 2014 Aug 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal growth factor receptor.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译